A nurse-led intervention to enhance medication adherence in ulcerative colitis (UC) using a concordance-led consultatio

Completed

• Conditions: lcerative colitis; Digestive System; Ulcerative colitis

• Registration Number: ISRCTN67674151
• Lead Sponsor: orthern Primary Care Research Network (NoReN) (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-04-28
• Last Update Posted: 21 August 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

Adults aged over 16 years with a diagnosis of ulcerative colitis (histologically proven), whose disease has been present for at least one year and who are found, from prescribing records, to be taking aminosalicylate (ASA) therapy at suboptimal levels (defined as using anything less than 8 months supply of aminosalicylates in a 12 month period). Patients who have been specifically told to stop taking their 5ASA medication will be screened out at the stage of initial patient invitation. Eligible patients who subsequently undergo total colectomy and therefore no longer require 5ASA therapy will no longer be eligible for inclusion in the study and will be classified as 'drop-out'.

Exclusion Criteria

Patients with self-limiting colitis or those whose UC has been diagnosed in the past year will be excluded. Patients aged less than 16 years are not eligible for inclusion and patients with significant neurological impairment such that they could not participate in the consultation will also be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified